21248. EXPRESIÓN MÍNIMA DE LOS SÍNTOMAS (MSE) Y RESPUESTA EN LAS ESCALAS ESPECÍFICAS EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA (MGG) CON ANTICUERPOS ANTI-ACHR (ACHR+) EN ADAPT/ADAPT+
| Published in: | Neurology Perspectives |
|---|---|
| Main Authors: | R. Sivera Mascaró, J. F Howard, H. Murai, S. Muppidi, G. Phillips, C. Qi, D. Gelinas, E. Brauer, S. Zhao, V. Bril, J. Vissing |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667049624008366 |
Similar Items
21245. EFGARTIGIMOD PH20 SUBCUTÁNEO (SC) EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA (MGG) EN ADAPTSC+: ANÁLISIS INTERMEDIO DE CALIDAD DE VIDA (QOL), EFICACIA, TOLERABILIDAD Y SEGURIDAD A LARGO PLAZO
by: R. Sivera Mascaró, et al.
Published: (2024-11-01)
by: R. Sivera Mascaró, et al.
Published: (2024-11-01)
Monosodium Glutamate Effect on The Expression of ɑ7nACHR and ɑ4nACHR Subunits in The Testicular Tissue
by: Raheleh Baradaran, et al.
Published: (2023-10-01)
by: Raheleh Baradaran, et al.
Published: (2023-10-01)
Congenital Myasthenic Syndrome and AChR Mutation
by: J Gordon Millichap
Published: (2000-09-01)
by: J Gordon Millichap
Published: (2000-09-01)
21088. RESPUESTA A ROZANOLIXIZUMAB A TRAVÉS DE CICLOS DE TRATAMIENTO EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA: UN ANÁLISIS POST HOC
by: G. Gutiérrez Gutiérrez, et al.
Published: (2024-11-01)
by: G. Gutiérrez Gutiérrez, et al.
Published: (2024-11-01)
Congenital Myasthenic Syndromes: End-Plate AChR Lack
by: J Gordon Millichap
Published: (1998-02-01)
by: J Gordon Millichap
Published: (1998-02-01)
Impact of Key Nicotinic AChR Subunits on Post-Stroke Pneumococcal Pneumonia
by: Sandra Jagdmann, et al.
Published: (2020-05-01)
by: Sandra Jagdmann, et al.
Published: (2020-05-01)
ACHR-positive generalized myasthenia gravis: The old is gold and the new is for us to explore
by: Fu Liong Hiew
Published: (2023-01-01)
by: Fu Liong Hiew
Published: (2023-01-01)
PKC and PKA regulate AChR dynamics at the neuromuscular junction of living mice.
by: Isabel Martinez-Pena y Valenzuela, et al.
Published: (2013-01-01)
by: Isabel Martinez-Pena y Valenzuela, et al.
Published: (2013-01-01)
Expression and Possible Role of Nicotinic Acetylcholine Receptor ε Subunit (AChRe) in Mouse Sperm
by: Yusei Makino, et al.
Published: (2021-01-01)
by: Yusei Makino, et al.
Published: (2021-01-01)
The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
by: Pawan T Ojha, et al.
Published: (2023-01-01)
by: Pawan T Ojha, et al.
Published: (2023-01-01)
Synergic action of MicroRNAs and Wnts delivered by motor neuron EVs in promoting AChR clustering
by: Rachele Agostini, et al.
Published: (2025-08-01)
by: Rachele Agostini, et al.
Published: (2025-08-01)
Performance of Serum m3AchR-Ab for Alpha-fetoprotein-negative Hepatocellular Carcinoma Diagnosis
by: Tuoheti YAKUFU·, Kainan ZHANG, Hui ZHAO, Dawuti WUBULITALIFU·, Rui ZHANG, Renyong LIN, Guodong LYU
Published: (2022-06-01)
by: Tuoheti YAKUFU·, Kainan ZHANG, Hui ZHAO, Dawuti WUBULITALIFU·, Rui ZHANG, Renyong LIN, Guodong LYU
Published: (2022-06-01)
Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG
by: Feng Liang, et al.
Published: (2024-03-01)
by: Feng Liang, et al.
Published: (2024-03-01)
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
by: Antonino Lupica, et al.
Published: (2022-04-01)
by: Antonino Lupica, et al.
Published: (2022-04-01)
Impaired gating of γ‐ and ε‐AChR respectively causes Escobar syndrome and fast‐channel myasthenia
by: Xin‐Ming Shen, et al.
Published: (2023-05-01)
by: Xin‐Ming Shen, et al.
Published: (2023-05-01)
Prueba terapéutica con neostigmina en paciente con miastenia gravis
by: Freddy Henríquez Varela
Published: (2011-10-01)
by: Freddy Henríquez Varela
Published: (2011-10-01)
Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity
by: Kun Jia, et al.
Published: (2025-09-01)
by: Kun Jia, et al.
Published: (2025-09-01)
The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis
by: Song Hu, et al.
Published: (2021-01-01)
by: Song Hu, et al.
Published: (2021-01-01)
Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times?
by: Megha Chetan Dhamne
Published: (2023-01-01)
by: Megha Chetan Dhamne
Published: (2023-01-01)
Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
by: Nairong Xie, et al.
Published: (2025-01-01)
by: Nairong Xie, et al.
Published: (2025-01-01)
Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain
by: Elena Cortés-Vicente, et al.
Published: (2025-01-01)
by: Elena Cortés-Vicente, et al.
Published: (2025-01-01)
P397: A case of congenital myasthenic syndrome with AChR deficiency due to biallelic variants in CHRNE gene
by: Aashish Batheja, et al.
Published: (2024-01-01)
by: Aashish Batheja, et al.
Published: (2024-01-01)
Site-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs
by: Zora Chui-Kuen Chan, et al.
Published: (2020-03-01)
by: Zora Chui-Kuen Chan, et al.
Published: (2020-03-01)
Analysis of a Novel Bacteriophage vB_AchrS_AchV4 Highlights the Diversity of <i>Achromobacter</i> Viruses
by: Laura Kaliniene, et al.
Published: (2021-02-01)
by: Laura Kaliniene, et al.
Published: (2021-02-01)
Severe relapsing autoimmune encephalitis with GABAA receptor, titin and AchR antibodies in a patient with thymoma: a case report
by: Melissa Boisclair, et al.
Published: (2024-05-01)
by: Melissa Boisclair, et al.
Published: (2024-05-01)
Reconstitution of an N-AChR from Brugia malayi, an evolved change in acetylcholine receptor accessory protein requirements in filarial parasites.
by: Jennifer D Noonan, et al.
Published: (2022-11-01)
by: Jennifer D Noonan, et al.
Published: (2022-11-01)
21086. REDUCCIÓN GRADUAL DE LA DOSIS DE CORTICOSTEROIDES DURANTE EL TRATAMIENTO CON ZILUCOPLÁN EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA: SEGUIMIENTO A 120 SEMANAS DE RAISE-XT
by: R. Juntas Morales, et al.
Published: (2024-11-01)
by: R. Juntas Morales, et al.
Published: (2024-11-01)
Nivolumab: «Tormenta inmune» en paciente con miastenia gravis previa
by: T. Montalvo Moraleda, et al.
Published: (2020-11-01)
by: T. Montalvo Moraleda, et al.
Published: (2020-11-01)
Análisis clínico-molecular en una paciente con miastenia congénita
by: Taryn Castro, et al.
Published: (2010-11-01)
by: Taryn Castro, et al.
Published: (2010-11-01)
Single‐cell atlas reveals heterogeneous response to FcRn blockade in anti‐AChR antibody‐positive generalised myasthenia gravis
by: Hui‐Ning Li, et al.
Published: (2025-08-01)
by: Hui‐Ning Li, et al.
Published: (2025-08-01)
Efficiency of cell-based assays in detecting AChR antibodies in myasthenia gravis sera with low antibody concentrations as determined by radioimmunoprecipitation assay
by: John S. Tzartos, et al.
Published: (2025-05-01)
by: John S. Tzartos, et al.
Published: (2025-05-01)
Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients
by: Eleonora Lekova, et al.
Published: (2022-09-01)
by: Eleonora Lekova, et al.
Published: (2022-09-01)
Single particle tracking of alpha7 nicotinic AChR in hippocampal neurons reveals regulated confinement at glutamatergic and GABAergic perisynaptic sites.
by: Thomas Bürli, et al.
Published: (2010-07-01)
by: Thomas Bürli, et al.
Published: (2010-07-01)
Actividad física en adolescentes con trastorno de ansiedad generalizada
by: Aldana Martinez
Published: (2024-12-01)
by: Aldana Martinez
Published: (2024-12-01)
Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy
by: Long He, et al.
Published: (2024-04-01)
by: Long He, et al.
Published: (2024-04-01)
Therapeutic Plasma Exchange in AChR-Ab Positive Generalized Myasthenia Gravis: A Real World Study About Its Early Response
by: Chen J, et al.
Published: (2024-04-01)
by: Chen J, et al.
Published: (2024-04-01)
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
by: Waheed W, et al.
Published: (2022-08-01)
by: Waheed W, et al.
Published: (2022-08-01)
21293. NUEVA VARIANTE EN GEN PRKRA EN DOS HERMANOS CON DISTONÍA GENERALIZADA
by: A. Gómez González, et al.
Published: (2024-11-01)
by: A. Gómez González, et al.
Published: (2024-11-01)
Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients
by: Marina Mané-Damas, et al.
Published: (2025-05-01)
by: Marina Mané-Damas, et al.
Published: (2025-05-01)
Magnetic vagus nerve stimulation alleviates myocardial ischemia-reperfusion injury by the inhibition of pyroptosis through the M2AChR/OGDHL/ROS axis in rats
by: Yao Lu, et al.
Published: (2023-11-01)
by: Yao Lu, et al.
Published: (2023-11-01)
Similar Items
-
21245. EFGARTIGIMOD PH20 SUBCUTÁNEO (SC) EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA (MGG) EN ADAPTSC+: ANÁLISIS INTERMEDIO DE CALIDAD DE VIDA (QOL), EFICACIA, TOLERABILIDAD Y SEGURIDAD A LARGO PLAZO
by: R. Sivera Mascaró, et al.
Published: (2024-11-01) -
Monosodium Glutamate Effect on The Expression of ɑ7nACHR and ɑ4nACHR Subunits in The Testicular Tissue
by: Raheleh Baradaran, et al.
Published: (2023-10-01) -
Congenital Myasthenic Syndrome and AChR Mutation
by: J Gordon Millichap
Published: (2000-09-01) -
21088. RESPUESTA A ROZANOLIXIZUMAB A TRAVÉS DE CICLOS DE TRATAMIENTO EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA: UN ANÁLISIS POST HOC
by: G. Gutiérrez Gutiérrez, et al.
Published: (2024-11-01) -
Congenital Myasthenic Syndromes: End-Plate AChR Lack
by: J Gordon Millichap
Published: (1998-02-01)
